CAS 2022215-59-2

Dostarlimab

CAS : 2022215-59-2

Dostarlimab (TSR-042) is an immune checkpoint inhibitor targeting PD-1, blocking its interaction with its ligands PD-L1 and PD-L2.

Degré de pureté : >95%

Couleur et forme : Liquid

Masse moléculaire : 144.18 kDa

Ref: TM-T76850

Dostarlimab

CAS : 2022215-59-2

Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands PD-L1 and PD-L2

Ref: 3D-CLA1530